13F Data
13F filer · CIK 1633313

Avoro Capital Advisors LLC

NEW YORK, NY · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$11.1B
+$971.5M vs prior
Positions
26
New / sold out
3 / 9
Added / reduced
11 / 3
Turnover
18.3%
buys $1.9B · sells $2.6B
Top-10 weight
79.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewASCENDIS PHARMA+5,111,111–+$1.4B
AddedCYTOKINETICS INC+1,666,666+50.0%+$142.0M
AddedDEFINIUM THERAPEUTICS INC+2,188,888+43.8%+$103.0M
AddedUNITED THERAPEUTICS CORP+147,777+5.6%+$80.1M
NewHEMAB THERAPEUTICS HLDGS INC+1,925,150–+$70.7M
AddedARROWHEAD PHARMACEUTICALS INC+655,556+6.1%+$53.4M
NewFAETH THERAPEUTICS INC+1,444,039–+$36.1M
AddedUNIQURE NV+768,182+12.9%+$35.4M
AddedVIRIDIAN THERAPEUTICS INC+1,000,000+66.7%+$18.4M
AddedAVALO THERAPEUTICS+923,333+65.5%+$17.1M
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outASCENDIS PHARMA-5,062,500-100.0%$-1.2B
Sold outAPELLIS PHARMACEUTICALS INC-12,222,222-100.0%$-491.7M
Sold outCENTESSA PHARMACEUTICALS PLC-11,430,455-100.0%$-454.0M
Sold outTERNS PHARMACEUTICALS INC-5,695,000-100.0%$-300.2M
Sold outSOLENO THERAPEUTICS INC-2,300,000-100.0%$-77.0M
Sold outALKERMES PLC-1,200,000-100.0%$-42.4M
Sold outUNITED THERAPEUTICS CORPCALL-380,000-100.0%$-10.3M
ReducedREVOLUTION MEDICINES INC-47,444-2.0%$-8.9M
ReducedVERA THERAPEUTICS INC-165,000-2.8%$-7.1M
Sold outMANNKIND CORP-2,200,000-100.0%$-5.4M
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $147.6MQ1 2015: $260.6MQ2 2015: $363.1MQ3 2015: $384.6MQ4 2015: $290.3MQ1 2016: $286.7MQ2 2016: $450.0MQ3 2016: $569.9MQ4 2016: $495.0MQ1 2017: $782.8MQ2 2017: $851.0MQ3 2017: $1.3BQ4 2017: $1.5BQ1 2018: $2.1BQ2 2018: $2.7BQ3 2018: $2.3BQ4 2018: $1.7BQ1 2019: $2.4BQ2 2019: $2.9BQ3 2019: $2.4BQ4 2019: $3.4BQ1 2020: $3.0BQ2 2020: $5.1BQ3 2020: $7.0BQ4 2020: $5.8BQ1 2021: $5.8BQ2 2021: $5.7BQ3 2021: $6.4BQ4 2021: $5.9BQ1 2022: $5.5BQ2 2022: $5.1BQ3 2022: $5.4BQ4 2022: $6.7BQ1 2023: $6.7BQ2 2023: $7.4BQ3 2023: $6.6BQ4 2023: $7.2BQ1 2024: $8.6BQ2 2024: $7.5BQ3 2024: $6.9BQ4 2024: $7.1BQ1 2025: $6.4BQ2 2025: $5.7BQ3 2025: $7.7BQ4 2025: $10.2BQ1 2026: $10.2BQ2 2026: $11.1B
Q4 2014Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1UNITED THERAPEUTICS CORPCOMMON2,777,777$1.5B13.52%
2ASCENDIS PHARMAORDINARY SHARES5,111,111$1.4B12.24%
3KRYSTAL BIOTECH INCCOMMON2,888,888$1.1B9.64%
4MADRIGAL PHARMACEUTICALS INCCOMMON1,833,333$984.4M8.84%
5ARGENX SESPONSORED ADR1,000,000$927.8M8.33%
6ARROWHEAD PHARMACEUTICALS INCCOMMON11,355,555$925.6M8.31%
7KYMERA THERAPEUTICS INCCOMMON7,474,747$857.1M7.70%
8REVOLUTION MEDICINES INCCOMMON2,297,000$430.2M3.86%
9CYTOKINETICS INCCOMMON4,999,999$425.9M3.82%
10CELCUITY INCCOMMON3,400,000$355.7M3.19%
16 more rows. Subscribe for $29/month to see every row, download the data and use the API.